GGrantIndex
Sort

39,280 grants matching leukemia

Zebrafish Screens for Genetic Modifiers and Human Application in T-ALL

$304,947
A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2009 · CA

Targeting IL-12/23 p40 Pathways for the Control of GVHD

$304,946
Xue-Zhong Yu · Medical University Of South Carolina · R01 · FY2014 · CA

A Novel Expansion of Primary Leukemia Stem Cells

$304,943
Stephen Edward Fischer · Arteriocyte, Inc. · R43 · FY2010 · CA

Retrovirus cell-to-cell transmission

$304,929
Walther H Mothes · Yale University · R01 · FY2015 · CA

Molecular Mechanisms Regulating Noncanonical NF-kB Signaling

$304,920
Shao-Cong Sun · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · GM

Genetic Control of Programmed Cell Death in Drosophila

$304,920
Andreas Bergmann · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · GM

T Cell receptor-induced NF-kB and JNK activation

$304,920
Xin Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · GM

Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules

$304,917
Aseem Z Ansari · University Of Wisconsin-Madison · R01 · FY2009 · CA

Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules

$304,917
Aseem Z Ansari · University Of Wisconsin-Madison · R01 · FY2010 · CA

Targeting Leukemia causing oncogene E2a-Pbx1 with synthetic molecules

$304,917
Aseem Z Ansari · University Of Wisconsin-Madison · R01 · FY2008 · CA

A New Murine Model for MPN: Pathololgy and Therapy of NF-E2 Overexpression

$304,900
Heike L Pahl · Icahn School Of Medicine At Mount Sinai · P01 · FY2014 · CA

Single Molecule HIV-1 NC/Gag-DNA Interactions

$304,885
Mark C Williams · Northeastern University · R01 · FY2010 · GM

Project 1: Biomarkers of Chemical Exposure and Leukemia Risk

$304,882
Martyn T Smith · University Of California Berkeley · P42 · FY2014 · ES

Function of zinc-finger transcription factor Gfi-1 in hematopoietic stem cells

$304,832
Hanno R Hock · Massachusetts General Hospital · R01 · FY2011 · CA

Pretargeted Radioimmunotherapy for Hematologic Malignancies

$304,825
Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2014 · CA

Wee Kinases and the Control of the Meiotic Cell Cycle

$304,824
Marco Conti · University Of California, San Francisco · R01 · FY2015 · GM

Core C: Survey Shared Resource Core

$304,799
Jessica Chubak · Kaiser Foundation Research Institute · P01 · FY2022 · CA

Translational Investigation of KRas & NF1 in Myeloid Leukemia

$304,773
Kevin M Shannon · University Of California, San Francisco · R37 · FY2015 · CA

Translational Investigation of KRas & NF1 in Myeloid Leukemia

$304,773
Kevin M Shannon · University Of California, San Francisco · R37 · FY2016 · CA

Clinical Research Support

$304,767
Richard M Stone · Dana-Farber Cancer Inst · P01 · FY2024 · CA

V(D)J recombination, genomic instability, and cancer

$304,763
New York University School Of Medicine · R01 · FY2002 · CA

Molecular mechanisms of gene silencing by H4 methylation

$304,722
Judd C Rice · University Of Southern California · R01 · FY2010 · GM

Senior Leadership

$304,701
Michael A Caligiuri · Ohio State University · P30 · FY2009 · CA

ACTIVATION OF IKB KINASE BY HTLV-I TAX

$304,623
Pennsylvania State Univ Hershey Med Ctr · R01 · FY2002 · CA

CDK6 in T cell development and cancer

$304,610
Philip W Hinds · Tufts Medical Center · R01 · FY2013 · CA